Skip to content
Catalyst

PapersPMID:26854844

Purslane Extract and Glucose Homeostasis in Adults with Type 2 Diabetes: A Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety.

Journal of medicinal food2016The record ↗

  1. Finding, very limited evidencelowersSystolic blood pressure

What moved

1 findingHow to read these marks →
  • “In the total cohort, systolic blood pressure declined significantly more in the PE group than the placebo group: -7.5 ± 5.0 versus -0.01 ± 0.3 mmHg, P < .0001.”
    Study
    RCT
    Duration
    3 months
    Dose studied
    three capsules of purslane extract per day for 12 weeks
    Population
    adults with type 2 diabetes treated with a single oral hypoglycemic agent at baseline in both arms

Study record

Design
randomised controlled trial
Species
human
Population
Adults with type 2 diabetes mellitus on a single oral hypoglycemic agent at baseline; purslane extract (PE) capsules vs matched placebo; abstract only
Participants
63
Comparator
placebo
Duration
84 days
Endpoints measured
2